BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Encap Drug Delivery Adds New Commercial Product to Portfolio


1/25/2012 9:24:37 AM

Livingston, United Kingdom, January 25, 2012 / B3C newswire / - Encap Drug Delivery, the world’s leading contract development and manufacturing organization (CDMO) totally dedicated to liquid and semi-solid (hot melt) filled capsules, announces the addition of a further pharmaceutical product to its portfolio of commercial products.

The privately held company, founded 23 years ago, has spent the last few years building its development services capability and has state of the art manufacturing facilities based in Livingston (United Kingdom). The company has been successfully audited by the European MHRA and USA FDA and has over 70 staff totally dedicated to the liquid fill hard capsule technology.

The company has development and commercial contracts with a large number of pharmaceutical and biotech clients across the major pharmaceutical markets (Europe, USA and Japan) and the company is now benefiting from the progression of these products through the development phase and into commercial manufacture.

Dr Stephen Brown (CEO) commented that he was delighted to have secured the commercial manufacturing contract for a proprietary pharmaceutical product that is currently licensed in Europe and is transferring to Encap from the existing CDMO. ‘This is a large volume, licensed pharmaceutical and the award of this contract demonstrates that in addition to its excellent development services capability, the company is able to provide a best in class commercially competitive manufacturing service.’

Encap is working closely with its client to prepare for the successful launch of this and other pharmaceutical products in 2012.

Dr Brown indicated that the company had now firmly established its credentials as an excellent development services and drug delivery partner (now 50% of the company’s revenues) and is now well placed to continue the expansion of its commercial manufacturing business. The company currently manufactures 10 commercial products and following the expansion of the manufacturing facility in 2008, the company strategy will be to add further commercial products in the coming years. This includes highly potent compounds or those which require special handling as the company now has dedicated high containment facilities within its Livingston site.

About Encap Drug Delivery

Encap was established in 1989 and is a global provider of oral drug delivery and pharmaceutical development services. The company provides clients with fully integrated analytical and formulation development services, clinical trial manufacturing and high volume commercial manufacturing. Encap’s state-of-the-art facility in the UK is the world’s largest development and manufacturing facility dedicated to liquid and semi-solid filled hard capsules.

For further information please contact:

Robbie Stewart

Encap Drug Delivery

Units 4, 5 & 6

Oakbank Park Way

Livingston

United Kingdom, EH53 0TH

Tel: +44 (0)1506 448080

E-mail: rstewart@encapdrugdelivery.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES